Stay in the loop! Subscribe to our newsletter and gain access to exclusive insights, trends, and news from the world of business and leadership. Don’t miss out!
A Union Jack–lit Manhattan skyscraper, British nobility, celebrities, and JPMorgan’s top brass come together for an unexpected royal birthday tribute. A Royal Celebration—Without the King—Lights Up Manhattan In a scene more reminiscent of London’s Mayfair than Midtown Manhattan, JPMorgan Chase CEO Jamie Dimon hosted
Eng. Mohammed Reza Madani, Chairman and Group CEO of Mohammed Reza Madani
In today’s founder economy, impact is the new currency of success. Few
Humanized Leadership: Looking Beyond the Badge In a world where organizations often
In a world where stability is often mistaken for success, Safaa Mustafa Saidaa
Hyundai Motor and Kia Corp have announced a strategic partnership with Baidu Inc to develop cutting-edge technologies for connected cars. The collaboration aims to
Tesla CEO Elon Musk made an unannounced visit to Beijing, where he is expected to discuss Tesla’s operations and future plans in China with senior
Google, a subsidiary of Alphabet Inc, has filed a motion urging a federal court in Virginia to dismiss the antitrust lawsuit brought
The U.S. Department of Justice (DOJ) has concluded its investigation into the Mercedes-Benz diesel emissions scandal, with the car manufacturer no longer
Deutsche Bank has announced that it anticipates being affected by a legal provision stemming from ongoing legal proceedings in the second quarter
Tesla intends to lay off 693 employees at its facilities located in Sparks, Nevada, as indicated by a government notice. The notice
Colgate-Palmolive, the toothpaste maker, has increased its forecast for annual organic sales growth, buoyed by resilient demand for its self-care and pet
Daimler Truck is facing a critical deadline to negotiate a new labor contract with over 7,300 hourly workers across six facilities in
Elon Musk’s recent decision to leverage existing product lines for new affordable vehicles instead of developing entirely new models is drawing comparisons
Merck & Co has revised its annual profit and revenue forecasts upward, buoyed by robust sales of its blockbuster cancer drug Keytruda.
